1. Home
  2. KRYS vs MGY Comparison

KRYS vs MGY Comparison

Compare KRYS & MGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • MGY
  • Stock Information
  • Founded
  • KRYS 2015
  • MGY 2017
  • Country
  • KRYS United States
  • MGY United States
  • Employees
  • KRYS N/A
  • MGY N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • MGY Oil & Gas Production
  • Sector
  • KRYS Health Care
  • MGY Energy
  • Exchange
  • KRYS Nasdaq
  • MGY Nasdaq
  • Market Cap
  • KRYS 4.3B
  • MGY 4.5B
  • IPO Year
  • KRYS 2017
  • MGY 2017
  • Fundamental
  • Price
  • KRYS $144.86
  • MGY $24.32
  • Analyst Decision
  • KRYS Strong Buy
  • MGY Hold
  • Analyst Count
  • KRYS 10
  • MGY 12
  • Target Price
  • KRYS $204.90
  • MGY $25.00
  • AVG Volume (30 Days)
  • KRYS 268.2K
  • MGY 2.0M
  • Earning Date
  • KRYS 11-03-2025
  • MGY 10-29-2025
  • Dividend Yield
  • KRYS N/A
  • MGY 2.49%
  • EPS Growth
  • KRYS 36.22
  • MGY N/A
  • EPS
  • KRYS 4.91
  • MGY 1.92
  • Revenue
  • KRYS $359,205,000.00
  • MGY $1,329,026,000.00
  • Revenue This Year
  • KRYS $34.33
  • MGY $1.00
  • Revenue Next Year
  • KRYS $47.84
  • MGY $3.46
  • P/E Ratio
  • KRYS $29.46
  • MGY $12.56
  • Revenue Growth
  • KRYS 116.08
  • MGY 2.67
  • 52 Week Low
  • KRYS $122.80
  • MGY $19.09
  • 52 Week High
  • KRYS $207.84
  • MGY $29.02
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 48.61
  • MGY 53.35
  • Support Level
  • KRYS $136.73
  • MGY $23.28
  • Resistance Level
  • KRYS $152.96
  • MGY $24.31
  • Average True Range (ATR)
  • KRYS 4.68
  • MGY 0.63
  • MACD
  • KRYS -0.69
  • MGY -0.04
  • Stochastic Oscillator
  • KRYS 50.09
  • MGY 50.36

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About MGY Magnolia Oil & Gas Corporation

Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquid (NGL) reserves. The company's oil and natural gas properties are located in Karnes County and the Giddings area in South Texas, where the Company targets the Eagle Ford Shale and Austin Chalk formations. Its objective is to generate stock market value over the long term through consistent organic production growth, high full-cycle operating margins, and an efficient capital program with short economic paybacks. The company's operating segment is acquisition, development, exploration, and production of oil and natural gas properties located in the United States.

Share on Social Networks: